108937 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on ester bonds (3.1) Ribonucleases RNAses, DNAses
Targeted Nuclear RNA Cleavage and Polyadenylation with CRISPR-Cas
#3602Novel tracrRNA system for Cas9
#3603METHODS AND COMPOSITIONS FOR DIRECTED GENOME EDITING
#3604CRISPR/CAS9 IN VITRO KIT
#3605Compositions and methods for the targeting of SOD1
#3606Nucleic acid sequence replacement by NHEJ
#3607Compositions for increasing polypeptide stability and activity, and related methods
#3608GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE
#3609Detergent composition
#3610TREATMENT OF SJOGREN'S DISEASE WITH NUCLEASE FUSION PROTEINS
#3611Polynucleotides encoding APOA1-PON1 fusion polypeptides
#3612Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) Inhibitors
#3613MESOPHILIC ARGONAUTE SYSTEMS AND USES THEREOF
#3614Genetically engineered T cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
#3615Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence
#3616NANOPARTICLE FOR DELIVERING RIBONUCLEOPROTEIN AND USE THEREOF
#3617Methods for increasing observed editing in bacteria
#3618Automated cell processing methods, modules, instruments, and systems
#3619Engineered proteins
#3620MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT CONE-ROD DYSTROPHY
#3621CRISPR-BASED METHODS AND NOVEL COMPOSITIONS FOR TREATING VASCULAR DISORDERS
#3622METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3623SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
#3624Increasing gene editing and site-directed integration events utilizing meiotic and germline promoters
#3625Systems and methods for modulating CRISPR activity
#3626Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
#3627Systems, methods, and compositions for RNA-guided RNA-targeting CRISPR effectors
#3628NOVEL CRISPR-CAS SYSTEMS FOR GENOME EDITING
#3629Materials and methods for modifying and paratransformation of arthropods
#3630Endonuclease 1 ribonucleases for cleaning
#3631Programmable nuclease compositions and methods of use thereof
#3632Compositions and methods for promoting homology directed repair
#3633Enzyme-pore constructs
#3634CELL-FREE PRODUCTION OF RIBONUCLEIC ACID
#3635Pharmaceutical compositions comprising gene-corrected primary cells
#3636UNIVERSAL DONOR CELLS
#3637Targeted non-viral DNA insertions
#3638Treatment Of Sepsis With PCSK9 And LDLR Modulators
#3639TALEN-BASED AND CRISPR/CAS-BASED GENE EDITING FOR BRUTON'S TYROSINE KINASE
#3640CRISPR COMPOSITIONS AND METHODS FOR PROMOTING GENE EDITING OF ADENOSINE DEAMINASE 2 (ADA2)
#3641COMPOSITIONS AND METHODS FOR HIGHLY EFFICIENT GENETIC SCREENING USING BARCODED GUIDE RNA CONSTRUCTS
#3642Inhibition of unintended mutations in gene editing
#3643DNase variants
#3644CRISPR gene therapy of fusion gene related cancers
#3645PaCas9 nuclease
#3646T cells with improved functionality
#3647Cleaving pre-fusion state SARS-CoV-2 spike protein
#3648METHODS FOR DESIGNING DNA BINDING PROTEIN CONTAINING PPR MOTIFS, AND USE THEREOF
#3649COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI
#3650CELL MEMBRANE PENETRATING CONJUGATES FOR GENE EDITING
#3651Methods for making genetic edits
#3652CIS CONJUGATIVE PLASMID SYSTEM
#3653CRISPR GENE EDITING FOR AUTOSOMAL DOMINANT DISEASES
#3654Compositions and methods of modifying a plant genome to produce a MS9, MS22, MS26, or MS45 male-sterile plant
#3655GENE-EDITING COMPOSITIONS AND METHODS TO MODULATE FAAH FOR TREATMENT OF NEUROLOGICAL DISORDERS
#3656METHODS AND COMPOSITIONS FOR INHIBITION OF CRISPR RE-CLEAVAGE EVENTS
#3657Recombinant type I CRISPR-Cas system and uses thereof for genome modification and alteration of expression
#3658Simultaneous multiplex genome editing in yeast
#3659Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
#3660SYSTEMS AND METHODS FOR COMPARTMENT SPATIAL ORGANIZATION
#3661Method for promoting n-acetylglucosamine synthesis by using GlcN6P responsive element
#3662Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3663COMPOSITION FOR INDUCING DEATH OF CELLS HAVING MUTATED GENE, AND METHOD FOR INDUCING DEATH OF CELLS HAVING MUTATED GENE BY USING COMPOSITION
#3664NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
#3665Materials and methods for treatment of usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)
#3666PROGRAMMABLE NUCLEASES AND METHODS OF USE
#3667NOVEL MAD NUCLEASES
#3668TRANSCRIPTIONAL RECORDING BY CRISPR SPACER ACQUISITION FROM RNA
#3669BIOMARKER FOR PREDICTING ABILITY OF MESENCHYMAL STEM CELLS TO PROLIFERATE AND MIGRATE
#3670SYSTEMS AND METHODS FOR MODULATING RNA
#3671Optimized mRNA encoding CAS9 for use in LNPs
#3672SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
#3673Detection method using kit for detecting plurality of target nucleic acids
#3674NONVIRAL GENERATION OF GENOME EDITED CHIMERIC ANTIGEN RECEPTOR T CELLS
#3675COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACID
#3676COMPOSITIONS AND METHODS OF USE FOR SMALL-MOLECULE REGULATION OF CRISPR-CAS9 ACTIVITY USING RNA APTAMERS
#3677METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163
#3678METHODS FOR DETERMINING INCREASED RISK OF CANCER DEVELOPMENT AND TREATING THE SAME
#3679Engineered human extracellular DNASE enzymes
#3680TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION
#3681METHODS FOR INCREASING FETAL HEMOGLOBIN CONTENT IN EUKARYOTIC CELLS AND USES THEREOF FOR THE TREATMENT OF HEMOGLOBINOPATHIES
#3682ARRAYED NUCLEIC ACID-GUIDED NUCLEASE OR NICKASE FUSION EDITING
#3683APP MODIFICATION VIA BASE EDITING USING THE CRISPR/CAS9 SYSTEM
#3684COMPOSITIONS AND METHODS FOR TRANSFERRING BIOMOLECULES TO WOUNDED CELLS
#3685PEPTIDE BARCODES FOR CORRELATING NUCLEIC ACID-GUIDED NUCLEASE OR NICKASE FUSION EDITING AND PROTEIN TRANSLATION IN A POPULATION OF CELLS
#3686METHODS AND COMPOSITIONS FOR NUCLEIC ACID-GUIDED NUCLEASE CELL TARGETING SCREEN
#3687COMPOSITIONS AND METHODS FOR NON-ANTIBIOTIC TREATING OF BACTERIAL INFECTIONS BY BLOCKING OR DISRUPTING BACTERIAL GENES INVOLVED IN VIRULENCE OR VIABILITY
#3688CRISPR DNA targeting enzymes and systems
#3689METHODS AND COMPOSITIONS FOR CELLULAR REPROGRAMMING
#3690Enzymes with RuvC domains
#3691RNA PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND USES THEREOF
#3692Engineered microorganisms and methods of making and using same
#3693Polypeptides having nuclease activity
#3694COMBINATION THERAPY FOR TREATING MUSCULAR DYSTROPHY
#3695MULTIPLEX GENOME EDITING OF IMMUNE CELLS TO ENHANCE FUNCTIONALITY AND RESISTANCE TO SUPPRESSIVE ENVIRONMENT
#3696BIOLOGICALLY INFORMED AND ACCURATE SEQUENCE ALIGNMENT
#3697CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS
#3698Nuclease-mediated genome editing of primary cells
#3699Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3700PRODUCTION METHOD FOR GENOME-EDITED CELLS
#3701REDUCED AND MINIMAL MANIPULATION MANUFACTURING OF GENETICALLY-MODIFIED CELLS
#3702HIGH-EFFICIENCY TRANSFECTION OF BIOLOGICAL CELLS USING SONOPORATION
#3703Inducible control of gene expression
#3704METHODS FOR NOMINATION OF NUCLEASE ON-/OFF-TARGET EDITING LOCATIONS, DESIGNATED "CTL-seq" (CRISPR Tag Linear-seq)
#3705SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
#3706Methods of making unbiased phage libraries
#3707Cure all for nucleic acid-guided cell editing in E. Coli
#3708NANOPORE MEMBRANE DEVICE AND METHODS OF USE THEREOF
#3709Variants of CRISPR from Prevotella and Francisella 1 (Cpf1)
#3710Optimized protein linkers and methods of use
#3711RNA-guided endonuclease fusion polypeptides and methods of use thereof
#3712REAGENTS AND METHODS FOR CONTROLLING PROTEIN FUNCTION AND INTERACTION
#3713Gene editing-based method of attenuating the beta-amyloid pathway
#3714gRNA targeting HPK1 and a method for editing HPK1 gene
#3715DETECTION OF SPECIFIC HLA ALLELES
#3716Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
#3717METHOD FOR GENE EDITING OF CELL ON THE BASIS OF CRISPR/CAS SYSTEM
#3718IMPROVED VECTOR SYSTEMS FOR CAS PROTEIN AND SGRNA DELIVERY, AND USES THEREFOR
#3719Genomic editing vector for , method for editing genome of using the same, and transgenic strains using the same
#3720COMPOSITIONS AND METHODS FOR INCREASING FETAL HEMOGLOBIN AND TREATING SICKLE CELL DISEASE
#3721GUIDE RNA FOR HSV-1 GENE EDITING AND METHOD THEREOF
#3722DNA CUTTING MEANS BASED ON CAS9 PROTEIN FROM DEFLUVIIMONAS SP.
#3723METHOD FOR INDUCING DELETION IN GENOMIC DNA
#3724Variants of CRISPR from Prevotella and Francisella 1 (Cpf1)
#3725COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACID
#3726MODIFIED Cas9 PROTEIN AND USE THEREOF
#3727THERAPEUTIC GENE EDITING FOR ELANE-ASSOCIATED DISEASE
#3728METHODS OF IDENTIFYING IMMUNOMODULATORY GENES
#3729Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
#3730T-CELL EXPRESSING CHIMERIC RECEPTOR
#3731GENE EDITING OF REPRODUCTIVE HORMONES TO REDUCE FERTILITY IN ICTALURUS PUNCTATUS
#3732STERILE FISH
#3733METHODS FOR PROTECTING PORCINE FETUSES FROM INFECTION WITH PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV)
#3734PROTECTED GUIDE RNAS (PGRNAS)
#3735Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3736TARGETED ACTIVE GENE EDITING AGENT AND METHODS OF USE
#3737Gene editing
#3738DUAL GUIDE RNA FOR CRISPR/CAS GENOME EDITING IN PLANTS CELLS
#3739CRISPR/CAS-related methods and compositions for treating herpes simplex virus
#3740NOVEL CAS9 ORTHOLOGS
#3741METHOD FOR THE GENERATION OF COMPACT TALE-NUCLEASES AND USES THEREOF
#3742CELLS FOR THE PRODUCTION OF VIRUSES AND METHODS OF USING THE SAME
#3743Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
#3744Methods of treating mitochondrial disorders
#3745CRISPR-CAS-BASED COMPOSITION FOR GENE CORRECTION
#3746IONIZABLE AMINE LIPIDS
#3747Genetically engineered hematopoietic stem cells and uses thereof
#3748MYB-RELATED TRANSCRIPTION FACTOR (MYPOP) AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR TUMOR THERAPY
#3749Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
#3750PROTEIN HAVING NUCLEASE ACTIVITY, FUSION PROTEINS AND USES THEREOF
#3751RNA-guided nucleases and active fragments and variants thereof and methods of use
#3752NUCLEIC ACID WATERMARKS TO ASSESS AND IMPROVE NUCLEIC ACID-GUIDED NUCLEASE OR NICKASE FUSION EDITING
#3753SYSTEMS AND METHODS FOR POLYNUCLEOTIDE SPATIAL ORGANIZATION
#3754MUTATIONS IN MADS-BOX GENES AND USES THEREOF
#3755NUCLEIC ACID-GUIDED NUCLEASE OF NICKASE FUSION EDITING OF METHYLATED NUCLEOTIDES
#3756PROGRAMMABLE NUCLEASES AND BASE EDITORS FOR MODIFYING NUCLEIC ACID DUPLEXES
#3757COMPOSITIONS AND METHODS FOR SELECTING BIALLELIC GENE EDITING
#3758CRISPR SYSTEM FOR GENOME EDITING
#3759Methods for increasing gene-editing frequencies in maize cells
#3760TARGETED ACTIVE GENE EDITING AGENT AND METHODS OF USE
#3761Simultaneous multiplex genome editing in yeast
#3762CRISPR/CPF1 SYSTEMS AND METHODS
#3763DNA cutting means based on Cas9 protein from biotechnologically significant bacterium Clostridium cellulolyticum
#3764CRISPR/CAS12J ENZYME AND SYSTEM
#3765METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
#3766POLYPEPTIDES HAVING RNASE ACTIVITY
#3767Endogenous Gag-based capsids and uses thereof
#3768Genome editing methods and constructs
#3769CATIONIC LIPID COMPOSITIONS FOR TISSUE-SPECIFIC DELIVERY
#3770COMPOSITIONS AND METHODS FOR NHEJ-MEDIATED GENOME EDITING
#3771SYSTEMS FOR CELL CONTROL
#3772METHODS AND COMPOSITIONS FOR EFFICIENT DELIVERY OF NUCLEIC ACIDS AND RNA-BASED ANTIMICROBIALS
#3773Nucleic acids encoding CRISPR-associated proteins and uses thereof
#3774Method for selecting cells based on CRISPR/Cas-mediated integration of a detectable tag to a target protein
#3775NON-TOXIC CAS9 ENZYME AND APPLICATION THEREOF
#3776GENE-EDITING SYSTEMS FOR EDITING A CYSTIC FIBROSIS TRANSMEMBRANE REGULATOR (CFTR) GENE
#3777Materials and methods for treatment of usher syndrome type 2A
#3778CRISPR-CAS SYSTEM FOR CLOSTRIDIUM GENOME ENGINEERING AND RECOMBINANT STRAINS PRODUCED THEREOF
#3779CRISPR-Cas12J effector polypeptides and methods of use thereof
#3780Evolution of TALENs
#3781NUCLEOTIDE-SPECIFIC RECOGNITION SEQUENCES FOR DESIGNER TAL EFFECTORS
#3782Binding agents to pre-fusion state SARS-CoV-2 spike protein
#3783METHODS AND COMPOSITIONS TO INDUCE OR SUPPRESS IMMUNE RESPONSES THROUGH THE USE OF MEMBRANE BOUND COMPLEMENT SPLIT PRODUCTS
#3784COMPOSITIONS FOR TREATING PATHOLOGICAL CALCIFICATION CONDITIONS, AND METHODS USING SAME
#3785Compositions and methods for organ specific delivery of nucleic acids
#3786METHODS FOR VARIANT DETECTION
#3787CRISPR/CAS12F ENZYME AND SYSTEM
#3788NOVEL VIRUS VECTOR AND METHODS FOR PRODUCING AND USING SAME
#3789METHODS FOR CONTROLLING MERISTEM SIZE FOR CROP IMPROVEMENT
#3790Serine recombinases mediating stable integration into plant genomes
#3791COMPOSITIONS AND METHODS FOR OCHROBACTRUM-MEDIATED GENE EDITING
#3792TRANS-ACTIVATED FUNCTIONAL RNA BY STRAND DISPLACEMENT AND USES THEREOF
#3793Selective Curbing of Unwanted RNA Editing (SECURE) DNA Base Editor Variants
#3794Therapeutic Nuclease Compositions and Methods
#3795CAS9-CAS9 FUSION PROTEINS
#3796METHODS AND COMPOSITIONS INVOLVING THERMOSTABLE CAS9 PROTEIN VARIANTS
#3797Genetically modified rat models for severe combined immunodeficiency (SCID)
#3798DWARFISM ANIMAL MODEL HAVING IGF-1 GENETIC MUTATION AND METHOD FOR PRODUCING SAME
#3799Cas-ready mouse embryonic stem cells and mice and uses thereof
#3800Methods and Compositions for the Detection of Host Protein Cleavage by Group IV Viral Proteases
#3801TRANSIENT REPORTERS AND METHODS FOR BASE EDITING ENRICHMENT
#3802Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
#3803Compositions and methods for detecting molecular targets on chromosomal DNA
#3804METHODS AND KITS FOR DEPLETION AND ENRICHMENT OF NUCLEIC ACID SEQUENCES
#3805Optimization of in vitro isolation of nucleic acids using site-specific nucleases
#3806CRISPR-BASED GENOME MODIFICATION AND REGULATION
#3807Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3808Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3809PLGA-PEG/PEI NANOPARTICLES AND METHODS OF USE
#3810CRISPR-LpCas9 GENE EDITING SYSTEM AND APPLICATION THEREOF
#3811Nucleic acid-guided nucleases
#3812Methods for genetic modification of plants
#3813TARGETED NON-VIRAL DNA INSERTIONS
#3814ARTIFICIAL RNA-GUIDED SPLICING FACTORS
#3815Gene-regulating compositions and methods for improved immunotherapy
#3816MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING
#3817RNA-GUIDED NUCLEASES AND DNA BINDING PROTEINS
#3818GENE EDITING SYSTEM FOR CORRECTING SPLICING DEFECTS
#3819Synthetic reverse transcriptases and uses thereof
#3820COMPOSITIONS AND METHODS FOR AIRWAY TISSUE REGENERATION
#3821Cell Line for Production of Marek's Disease Virus Vaccine and Methods of Making and Using the Same
#3822METHOD FOR DETECTING NUCLEIC ACID
#3823Methods and systems for monomer chain formation
#3824METHODS AND COMPOSITIONS FOR CRISPR EDITING OF CELLS AND CORRELATING THE EDITS TO A RESULTING CELLULAR NUCLEIC ACID PROFILE
#3825Synthetic immunomodulation with a CRISPR super-repressor in vivo
#3826CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
#3827RNA-GUIDED TRANSCRIPTIONAL REGULATION AND METHODS OF USING THE SAME FOR THE TREATMENT OF BACK PAIN
#3828Methods of Identifying Adenosine-to-Inosine Edited RNA
#3829CRISPR-Cas effector polypeptides and methods of use thereof
#3830CRISPR-associated transposases and uses thereof
#3831METHODS OF EDITING SINGLE NUCLEOTIDE POLYMORPHISM USING PROGRAMMABLE BASE EDITOR SYSTEMS
#3832Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof
#3833GENE EDITING OF MONOGENIC DISORDERS IN HUMAN HEMATOPOIETIC STEM CELLS -- CORRECTION OF X-LINKED AGAMMAGLOBULINEMIA (XLA)
#3834CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS
#3835Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides
#3836METHODS FOR CONTROLLING MERISTEM SIZE FOR CROP IMPROVEMENT
#3837RNA MEDIATED GENE REGULATING METHODS
#3838METHODS OF SUPPRESSING PATHOGENIC MUTATIONS USING PROGRAMMABLE BASE EDITOR SYSTEMS
#3839Compositions for genome editing
#3840METHODS OF INHIBITING PROLIFERATIVE CELLS
#3841Composition for modifying target gene
#3842Non-standard amino acid containing compositions and uses thereof
#3843Antibody-evading virus vectors
#3844Virus vectors for targeting ophthalmic tissues
#3845Exosomes Comprising RNA Therapeutics
#3846Nanoliposome-microbubble conjugate having complex of Cas9 protein, guide RNA inhibiting SRD5A2 gene expression and cationic polymer encapsulated in nanoliposome and composition for ameliorating or treating hair loss containing the same
#3847METHODS, MODELS, SYSTEMS, AND APPARATUS FOR IDENTIFYING TARGET SEQUENCES FOR CAS ENZYMES FOR CRISPR-CAS SYSTEMS FOR TARGET SEQUENCES AND CONVEYING RESULTS THEREOF
#3848Determination of base modifications of nucleic acids
#3849DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS ELANE GENE
#3850IN VIVO HOMOLOGY DIRECTED REPAIR IN HEART, SKELETAL MUSCLE, AND MUSCLE STEM CELLS
#3851CRISPR/CAS-RELATED METHODS AND COMPOSITIONS TARGETING VIRUS GENOMES
#3852CRISPR/CAS Systems For Treatment of DMD
#3853Target sequence specific alteration technology using nucleotide target recognition
#3854MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING
#3855Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein
#3856Cell data recorders and uses thereof
#3857Gene Targeting
#3858Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway
#3859GENETICALLY ENGINEERED CAR T CELLS THAT SECRET INTERLEUKIN-12 AND THERAPEUTIC USES THEREOF
#3860DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING VIRAL COMPONENTS
#3861INHIBITORS OF RNA-GUIDED NUCLEASE ACTIVITY AND USES THEREOF
#3862ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION AND THERAPEUTIC METHODS
#3863Method for Modulating RNA Splicing by Inducing Base Mutation at Splice Site or Base Substitution in Polypyrimidine Region
#3864MATERIALS AND METHODS FOR THE CORRECTION OF RETINITIS PIGMENTOSA
#3865CARGO LOADED EXTRACELLULAR VESICLES
#3866Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas Effector Enzymes
#3867Methods and kits for identifying cancer treatment targets
#3868Method For Creating Reference Cell Lines With Simultaneous Genetic Variants And Accurate Quantification Of Alelle Frequency
#3869Bifunction chemical epigenetic modifiers and methods of use
#3870OPTIMIZED BASE EDITORS ENABLE EFFICIENT EDITING IN CELLS, ORGANOIDS AND MICE
#3871Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
#3872Optimized protein linkers and methods of use
#3873Engineered CRISPR-Cas9 Nucleases
#3874Method for treating muscular dystrophy by targeting utrophin gene
#3875Messenger RNA encoding Cas9 for use in genome-editing systems
#3876Nucleic acid molecules encoding nuclease-albumin fusion proteins
#3877Engineered red blood cells having rare antigen phenotypes
#3878Targeted replacement of endogenous T cell receptors
#3879HIGH THROUGHPUT METHOD AND SYSTEM FOR MAPPING INTRACELLULAR PHASE DIAGRAMS
#3880RAPID FIELD-DEPLOYABLE DETECTION OF SARS-CoV-2 VIRUS
#3881DETECTION OF NUCLEIC ACIDS
#3882HIV or HCV detection with CRISPR-CAS13A
#3883METHOD FOR FAST GENE EDITING AND CONSTRUCTING PRIMATE DISEASE MODEL
#3884Universal donor cells
#3885GENERATION OF HERITABLY GENE-EDITED PLANTS WITHOUT TISSUE CULTURE
#3886Genetic toolbox for metabolic engineering of non-conventional yeast
#3887Pig with a genetically modified CD163 gene resistant to PRRSv
#3888GENE EDITING BASED CANCER TREATMENT
#3889COMPOSITIONS AND METHODS FOR DELIVERING TRANSGENES
#3890NOVEL CRISPR ENZYMES AND SYSTEMS
#3891NOVEL CRISPR ENZYMES AND SYSTEMS
#3892sp. CAS12A mutants with enhanced cleavage activity at non-canonical TTTT protospacer adjacent motifs
#3893NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION
#3894THERAPEUTIC TARGETING OF MALIGNANT CELLS USING TUMOR MARKERS
#3895Endogenous Gag-based capsids and uses thereof
#3896RNA targeting methods and compositions
#3897RNA targeting methods and compositions
#3898RNA targeting methods and compositions
#3899RNA targeting methods and compositions
#3900RNA targeting methods and compositions